FogPharma logo

Fog Pharmaceuticals, Inc.

Biotechnology

FogPharma Stock

FogPharma develops cell-penetrating mini proteins (CPMPs) designed to target and neutralize cancer-causing proteins within cancer cells. These innovative therapeutics aim to treat cancer-related diseases by reaching targets that conventional treatments cannot address.

Founded: 2015

FogPharma Website

FogPharma Company Overview

null

Management Team

Mathai Mammen Ph.D. Chief Executive Officer, President & Chairman
Kristen Stants Chief People Officer
Gregory Miller Chief Business Officer
Brandon Allgood Ph.D. Chief Data Officer
Keith Orford MD Chief Medical Officer & Executive Vice President of Clinical and Translational Science
John McGee Ph.D. Scientific Co-Founder, Vice President of De Novo Discovery & Head of De Novo Discovery
Weiqing Zhou Co-Founder & Chief Operating Officer
Rohin Mhatre Ph.D. Chief Technical Operations Officer & Executive Vice President
Gregory Verdine Ph.D. Co-Founder, Vice Chairman & Special Advisor

Funding Information